Prophylactic Intravitreal Bevacizumab before Cataract Surgery in Diabetics: Effect on Postoperative Macular Thickness
Preoperative bevacizumab significantly limited postoperative macular thickening in diabetic patients undergoing cataract surgery and remained significant across age, sex, and comorbidity subgroups.